Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Journal of Managed Care & Specialty Pharmacy|March 5, 2019
Evaluation of Treatment Patterns and Costs in Patients with Prostate Cancer and Bone MetastasesLonnie Wen, Jianying Yao, Adriana ValderramaImmunotherapy|April 11, 2026
Pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction cancer: KEYNOTE-859 Q-TWiST analysisLucjan Wyrwicz, Vasiliki Kalampoki, Adriana Valderrama, et al.American Health & Drug Benefits|July 27, 2019
Real-World Treatment Patterns in Patients with Castrate-Resistant Prostate Cancer and Bone MetastasesLonnie Wen, Adriana Valderrama, Mary E Costantino, et al.Leukemia & Lymphoma|April 15, 2016
Indirect costs and workplace productivity loss associated with non-Hodgkin lymphomaJustin S Yu, Ryan N Hansen, Adriana Valderrama, et al.Medicine|January 26, 2018
Sorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma: A retrospective, multi-institutional cohort studyDavid E Kaplan, Rajni Mehta, Kathryn D'Addeo, et al.Current Medical Research and Opinion|May 9, 2012
Modelling survival in hepatocellular carcinomaNoemi Muszbek, Noemi Kreif, Adriana Valderrama, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 24, 2018
Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer PatientsYue Zhong, Adriana Valderrama, Jianying Yao, et al.Journal of Clinical Gastroenterology|September 10, 2015
Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health InsuranceDavid S Goldberg, Adriana Valderrama, Rajesh Kamalakar, et al.Frontiers in Oncology|January 28, 2026
Real-world clinical characteristics and outcomes of patients with locally advanced, unresectable esophageal/gastroesophageal junction cancer treated with definitive chemoradiotherapy in the United States community oncology settingAdriana Valderrama, Karthik Ramakrishnan, Lisa Herms, et al.Journal of Managed Care & Specialty Pharmacy|December 24, 2025
Treatment patterns, health care resource utilization and costs, and clinical outcomes among older adult patients with advanced HER2-positive gastric or gastroesophageal junction adenocarcinomaLiya Wang, Aolin Wang, Adriana Valderrama, et al.Pageof 3